- Cancer Care Team
Cancer Care Team
To deliver optimal patient outcomesProducts and Services
Cancer Type
Supplies & Tools
Scientific Focus
- Biopharma Partners
- Patients
- Education & Events
- Login
- Contact Us
This one-page document summarizes our published manuscript in Frontiers in Oncology, where the PGDx elio tissue complete assay demonstrated 100% concordance with IHC, FISH and RNA profiling for the detection of ALK rearrangements in NSCLC.
Covering a 505-gene panel aligned to CDx and National Comprehensive Cancer Network® (NCCN®) guideline targets, the FDA-cleared, CE-IVD marked PGDx elio™ tissue complete assay is now available in our Baltimore, Geneva and Shanghai laboratories, as the Labcorp Tissue Complete service.